Neuren Pharmaceuticals Limited
www.neurenpharma.comNeuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.
Read more
Neuren Pharmaceuticals (ASX: NEU) is developing new therapies for six debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.
Read more
Country
City (Headquarters)
Camberwell
Industry
Employees
11-50
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Product Development and Technical Affairs
Email ****** @****.comPhone (***) ****-****Vice President , Clinical Operations
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
Reach decision makers at Neuren Pharmaceuticals Limited
Free credits every month!
Neuren Pharmaceuticals Limited FAQ
Camberwell, Australia
Pharmaceutical Manufacturing
